The EPS beat and US commercial ramp are positive signals, but with only one quarter of post-FDA data and no guidance, the trajectory is uncertain. Monitor next quarter for sustained revenue growth and cash burn.
Price Chart
Executive Summary
Nyxoah reported Q1 2026 EPS of $-0.37, beating consensus of $-0.44 (15.5% beat), while revenue of $7.6M was in line. The press release highlighted early US commercial momentum of the Genio system post-FDA approval. The EPS beat is positive but occurred on a small base, and no guidance was provided.
Key Financial Metrics
Key Facts
- Q1 2026 EPS $-0.37 vs consensus $-0.44 (15.5% beat)
- Revenue $7.6M in line with consensus
- Press release emphasizes strong early US commercial progress for Genio system
- No guidance or forward-looking financial metrics provided
Financial Impact
EPS beat by $0.07 (15.5%) on consensus of -$0.44; revenue in line at $7.6M
Risk Factors
- Early-stage revenue base ($7.6M quarterly) makes growth comparisons volatile
- No guidance provided, limiting forward visibility
- Potential dilution risk given cash burn for commercial expansion
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3298846 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $0.8950 $0.8220 | ▲ +8.16% | ▲ +6.98% | $0.8560 (+4.36%) |
Oct 19, 2026 8d ago | Press Release | $0.9540 $0.9400 | ▲ +1.47% | ▲ +1.80% | $0.8560 (+10.27%) |
Sep 22, 2026 4w ago | 6-K | $1.33 $1.27 | ▼ −4.51% | ▼ −4.43% | $0.8560 (−35.64%) |
Jun 23, 2026 17w ago | 6-K | $1.62 $1.63 | ▼ −0.62% | ▼ −0.47% | $0.8560 (+47.16%) |
Jun 11, 2026 19w ago | 6-K | $1.39 $1.55 | ▼ −11.51% | ▼ −9.75% | $0.8560 (+38.42%) |
Jun 8, 2026 20w ago | 6-K | $1.34 $1.31 | ▲ +2.24% | ▲ +0.66% | $0.8560 (+36.12%) |
Jun 8, 2026 20w ago | 424B5 | $1.39 $1.34 | ▲ +3.60% | ▲ +3.30% | $0.8560 (+38.42%) |
Jun 5, 2026 20w ago | Press Release | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.8560 (+40.97%) |
Jun 4, 2026 20w ago | 424B5 | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.8560 (+40.97%) |
May 20, 2026 22w ago | Press Release | $2.87 $2.87 | · 0.00% | ▼ −0.45% | $0.8560 (−70.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers